EP2301955
Hlaupabólu-ristilveirubóluefni
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
1.3.2006EP published:
18.4.2018EP application number:
10188215.7
EP translation filed:
6.6.2018Grant published:
15.6.2018EPO information:
European Patent Register
Max expiry date:
28.2.2026Expiry date:
28.2.2026
Title:
Varicella Zoster virus vaccine
Timeline
Today
1.3.2006EP application
18.4.2018EP Publication
6.6.2018Translation submitted
15.6.2018Registration published
28.2.2026Expires
Owner
Name:
GlaxoSmithKline Biologicals SAAddress:
Rue de l'Institut 89, 1330, Rixensart, BE
Inventor
Name:
Hanon, Emmanuel JulesAddress:
Rixensart, BE
Name:
Stephenne, JeanAddress:
Rixensart, BE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
0504436Date:
3.3.2005Country:
GB
Classification
Categories:
C07K 14/04, A61K 39/25, A61K 39/39, A61P 31/22
Annual fees
Number
Paid
Expires
Payer
Number: 14
Paid: 14.2.2019
Expires: 29.2.2020
Payer: Örn Þór, slf.
Number: 15
Paid: 14.2.2020
Expires: 28.2.2021
Payer: Örn Þór slf.
Number: 16
Paid: 10.2.2021
Expires: 28.2.2022
Payer: Örn Þór slf.
Number: 17
Paid: 17.2.2022
Expires: 28.2.2023
Payer: Patice ehf.
Number: 18
Paid: 22.2.2023
Expires: 28.2.2024
Payer: Árnason Faktor ehf.
Number: 19
Paid: 29.2.2024
Expires: 28.2.2025
Payer: Árnason Faktor ehf.
Number: 20
Paid: 21.2.2025
Expires: 28.2.2026
Payer: Árnason Faktor ehf.